form8k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

September 21, 2012
Date of Report (date of earliest event reported)


 
Cutera, Inc.
(Exact name of Registrant as specified in its charter)

Delaware
 
000-50644
 
77-0492262
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)

3240 Bayshore Blvd.
Brisbane, California 94005
(Address of principal executive offices)

(415) 657-5500
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
 
(b)
On September 21, 2012, Cutera, Inc. (the “Company”) announced that Len DeBenedictis, Chief Technology Officer, decided to leave the Company to pursue other personal interests.
 
Item 9.01.
Financial Statements and Exhibits
 
(d) Exhibits.

Exhibit No.
  
Description
   
  
Press Release of Cutera, Inc. dated September 21, 2012

 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
CUTERA, INC.
     
Date:  September 21, 2012.
By:
  /s/ Ronald J. Santilli
   
Ronald J. Santilli
Executive Vice President and Chief Financial Officer

 

ex99_1.htm

Exhibit 99.1
 

 
FOR IMMEDIATE RELEASE

CONTACTS:

Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500

Investor Relations
John Mills
Integrated Corporate Relations, Inc.
310-954-1105
john.mills@icrinc.com

Cutera Appoints Michael Karavitis as Vice President of Research and Development

BRISBANE, California, September 21, 2012 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy based aesthetic systems for practitioners worldwide, today announced that Michael Karavitis, Ph.D., has recently joined the Company as Vice President of Research and Development.

Kevin Connors, President and CEO of Cutera stated, "We are excited to have Michael leading our research and development efforts. Prior to joining Cutera, Michael led a team of engineers and scientists at various successful early to mid stage companies, including LenSx (acquired by Alcon), Newport Corporation and Intralase Corporation (acquired by Advanced Medical Optics).  He holds multiple patents and is the author of several publications in the fields ranging from Laser science to biotechnology.  Michael will be succeeding Len DeBenedictis, who decided to leave the Company to pursue other personal interests.”

Mr. Connors added, “We are confident that with Michael’s leadership we will continue our history of introducing innovative solutions for the aesthetics market. In August 2012, we commenced shipments of our truSculpt product and we plan to continue investing in our research and development activities.”

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.